Canary Foundation   Report issue

Foundation Phase 2 Phase 3
Founded: Palo Alto CA United States (2004)

Organization Overview

First Clinical Trial
2019
NCT03824535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Canary Foundation